Thrombin time and fibrinogen as initial screening tests for people with inherited bleeding disorders

Haemophilia

Volumn 16, Issue 4, 2010, Pages 700-701

  Puetz, J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

BLEEDING DISORDER; BLOOD CLOTTING TEST; FALSE POSITIVE RESULT; FIBRINOGEN BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; THROMBIN TIME;

BLOOD COAGULATION DISORDERS, INHERITED; BLOOD COAGULATION TESTS; FEMALE; FIBRINOGEN; HUMANS; MALE; MASS SCREENING; MENORRHAGIA; PREDICTIVE VALUE OF TESTS; THROMBIN TIME;

EID: 77954847978     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2010.02219.x     Document Type: Letter

References (3)

1. Nichols W, Hultin M, James A. von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel Report (USA). Haemophilia 2008, 14:171-232.
2. Medical and Scientific Advisory Council of the National Hemophilia Foundation Recommendation # 185: MASAC Recommendation Regarding Women with Inherited Bleeding Disorders. http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=1192, Available at. Accessed May 29, 2009
3. Acharya S, Dimichele D. Rare inherited disorders of fibrinogen. Haemophilia 2008, 14:1151-8.